100Xfounder
Get Featured

Building AI Copilots & Agents for Psychiatry. Come make mental healthcare affordable, accessible, and clinically-effective for every American. Artificial Intelligence Healthcare

About Blossom

The Problem Artificial Intelligence teams often struggle with fragmented workflows, slow decision cycles, and unclear accountability when they try to solve important operating problems with generic tools. For Blossom, the core problem is turning that category pressure into a focused product motion for customers operating in or around New York, New York, USA.

The Solution Blossom's profile describes the company as "Building AI Copilots & Agents for Psychiatry. Come make mental healthcare affordable, accessible, and clinically-effective for every American. Artificial Intelligence Healthcare". The practical solution angle is a focused layer for artificial intelligence teams: reduce manual coordination, improve decision visibility, and give customers a clearer way to act on the workflow that the company has chosen to own.

Buyer Context Blossom's buyer context starts with founders, operators, investors, partners, and business teams evaluating the category. In Artificial Intelligence, those readers usually care about clarity, speed of rollout, operational fit, reliability, and measurable outcomes. The practical question is whether "Building AI Copilots & Agents for Psychiatry. Come make mental healthcare affordable, accessible, and clinically-effective for every American. Artificial Intelligence Healthcare" can translate into a product story tied to real workflow pressure and a credible path to customer value for customers operating in or around New York, New York, USA.

Market Timing Artificial Intelligence is being shaped by shifting customer expectations, faster digital adoption, and pressure to show measurable operating value. That timing matters for Blossom because series A execution usually means the company is turning early traction into a repeatable sales, product, and customer success motion. The profile is most useful when readers connect that stage context with the realities of building from New York, New York, USA.

Operating Signals Team size is listed as 1-10 employees, suggesting a focused early build phase. Funding context is Headline, Village Global, Operator Partners, Correlation Ventures, Founder of General Catalyst, $20M Series A in 2025. Hiring is active, with visible role focus in Open Roles. Read together, these signals help explain whether Blossom is still validating a focused wedge, scaling a repeatable motion, or preparing for broader strategic milestones.

Comparison Lens Blossom is best compared with companies sharing Artificial Intelligence and Series A signals. Against that peer set, look at product specificity, stage maturity, geographic operating base, funding context, and whether hiring points toward product, sales, operations, or customer delivery.

Research Checklist

  • Map the customer segment behind "Building AI Copilots & Agents for Psychiatry. Come make mental healthcare affordable, accessible, and clinically-effective for every American. Artificial Intelligence Healthcare" to the core workflow pressure inside Artificial Intelligence.
  • Compare Series A progress with companies operating from New York, New York, USA and adjacent Artificial Intelligence categories.
  • Read the funding context alongside team size to judge whether resources match the stated market opportunity.
  • Use role focus in Open Roles to infer where the company is investing next.
  • Review connected founder, funding, news, and peer-company pages before making a partnership, hiring, or market-mapping decision.

What to Watch Next Blossom's next useful signals are how funding context turns into sharper product depth, stronger distribution, or new market coverage, whether hiring in Open Roles becomes visible in product, sales, operations, or customer delivery, and whether Blossom deepens its position in Artificial Intelligence beyond the current profile snapshot.

Culture The available profile points to a culture built around focused execution: product clarity from the artificial intelligence category, customer awareness from the one-liner, and disciplined prioritization from the company's stage, team size, funding context, and hiring signals.

Why it Matters

Blossom matters now because blossom has a stronger timing story when viewed against shifting customer expectations, faster digital adoption, and pressure to show measurable operating value. The company's opportunity depends on turning category urgency into repeatable adoption, durable customer proof, and a sharper operating model. Team size is listed as 1-10 employees, suggesting a focused early build phase. Funding context is Headline, Village Global, Operator Partners, Correlation Ventures, Founder of General Catalyst, $20M Series A in 2025. Hiring is active, with visible role focus in Open Roles. Read together, these signals help explain whether Blossom is still validating a focused wedge, scaling a repeatable motion, or preparing for broader strategic milestones.

Market Context for Blossom

Blossom sits inside the Artificial Intelligence market, where buyers usually compare vendors on speed, trust, implementation depth, and the ability to show measurable outcomes. The company's current profile points to Series A stage execution, a primary operating base around New York, New York, USA, and a funding signal of $20.00M. Those details help readers separate a basic company listing from a stronger operating brief.

For founders and operators, the useful question is not only what Blossom sells, but whether the company is building repeatable go-to-market motion in its category. The product summary, founder footprint, hiring status, and Series A at Headline, Village Global, Operator Partners, Correlation Ventures, Founder of General Catalyst, $20M Series A in 2025 give a practical way to read momentum. If the company is hiring, it may signal new customer demand, product expansion, or regional growth. If hiring is quiet, readers can still compare product focus, funding history, and peer activity before drawing conclusions.

Use this page as a research starting point for the company, then move into connected founder profiles, industry hubs, funding-stage pages, and related company comparisons. That route gives a clearer picture of where Blossom fits in the market and which adjacent companies are moving in the same direction.

Category Lens

Compare Blossom with other Artificial Intelligence companies to understand peer density, buyer demand, and market maturity.

Funding Lens

Track Series A signals, total funding, and round history to judge whether the company is still proving demand or scaling execution.

People Lens

Founder background, open roles, and team size show how the company is investing in product, sales, operations, and customer delivery.

Funding Snapshot

Total Funding: $20.00MLast Round: Series A Headline, Village Global, Operator Partners, Correlation Ventures, Founder of General Catalyst, $20M Series A in 2025All Rounds: 1
  • Series AHeadline, Village Global, Operator Partners, Correlation Ventures, Founder of General Catalyst, $20M Series A in 2025

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

AWSReactPythonPostgreSQL

Last updated: February 23, 2026

Blossom intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

The highest-signal way to use this page is to read it as a company brief, not just a static directory listing. Look at how the product summary, funding context, hiring activity, and founder footprint fit together. When these signals align, the page becomes more useful for investors, operators, and founder-research workflows than a basic profile card or shallow company database entry.

Related Companies

Alternatives in Artificial Intelligence with comparable market signals.

Discover Now

Newsroom and topic pages connected to Blossom.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About Blossom

Common questions people ask about this profile.

What is Blossom?

Building AI Copilots & Agents for Psychiatry. Come make mental healthcare affordable, accessible, and clinically-effective for every American. Artificial Intelligence Healthcare

Who founded Blossom?

Blossom is associated with Blossom Team on 100Xfounder.

Where is Blossom located?

Blossom is listed in New York, New York, USA.

What stage is Blossom in?

Blossom is currently mapped to Series A. Funding context: Headline, Village Global, Operator Partners, Correlation Ventures, Founder of General Catalyst, $20M Series A in 2025

What is the latest funding round of Blossom?

Blossom's latest tracked round is Series A Headline, Village Global, Operator Partners, Correlation Ventures, Founder of General Catalyst, $20M Series A in 2025. Total tracked rounds: 1.

Is Blossom hiring now?

Blossom hiring status: Open Roles.

What technologies does Blossom use?

Blossom is associated with AWS, React, Python, and PostgreSQL.

Is Blossom verified on 100Xfounder?

Yes. Blossom is currently marked verified on 100Xfounder as of July 23, 2026.

How can users connect with Blossom founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.